Combinostics will be attending the ECR conference in Vienna 27 February – 3 March. We will showcase our cNeuro® cMRI application for quantitative analysis of MRI scans, and our cNeuro® cDSI application for clinical decision support in dementia. You will find us in the AI-Exhibition (close to EXPO X1), booth AI-24. Please come and visit us!
Combinostics today announced that it has entered an agreement with the Swedish company SyntheticMR where SyntheticMR, subject to approval by an Extraordinary General Meeting, will acquire all shares in Combinostics.
New cDAT application for for automated quantification of DAT SPECT images further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics US Inc.
177 Huntington Ave
17th Floor
Boston, MA 02115, USA
© Combinostics | Privacy Policy
